fr

Aeson® total artificial heart highlighted as a very promising solution for heart failure patients with pulmonary hypertension in The Journal of Heart and Lung Transplantation

Implantation of the CARMAT heart in a 3rd patient at the Georges Pompidou European Hospital

Download

Airbus Group joins the CARMAT Board of Directors

Download

2014 annual results

Download

CARMAT subscribes to a new contingent equity line with Kepler Cheuvreux

Download

CARMAT will benefit from the European SEED program that supports innovative therapy developers seeking reimbursement

Download

The patient who received a CARMAT bioprosthetic heart in Nantes on August 5, 2014 has been discharged home

Download

2015 financial agenda

Download

CARMAT secures its cash position by reaching milestone n°5 of its contract with Bpifrance, and receives €5.3m

Download
Top of page